NodThera Limited
Patent Applications and Registrations
Patent applications and USPTO patent grants for NodThera Limited.The latest application filed is for "sulfonamide derivatives and uses thereof".
- NodThera Limited - Essex GB
| Patent | Date |
|---|---|
| Sulfonamide Derivatives And Uses Thereof App 20220267300 - BOCK; Mark G. ; et al. | 2022-08-25 |
| Sulfonylurea Derivatives And Uses Thereof App 20220227715 - BOCK; Mark G. ; et al. | 2022-07-21 |
| Urea derivatives and methods of use thereof Grant 11,345,669 - Harrison , et al. May 31, 2 | 2022-05-31 |
| Carbamate Derivatives And Uses Thereof App 20220098159 - BOCK; Mark G. ; et al. | 2022-03-31 |
| Selective Inhibitors Of Nlrp3 Inflammasome App 20210087147 - BOCK; Mark G. ; et al. | 2021-03-25 |
| Sulphonyl Urea Derivatives As Nlrp3 Inflammasome Modulators App 20210002261 - HARRISON; David ; et al. | 2021-01-07 |
| Chemical Compounds App 20200131141 - HARRISON; David ; et al. | 2020-04-30 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 